Sorrento Therapeutics Inc SRNE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
8.94quote price arrow up+0.06 (+0.68%)
Volume
130,039
Close
8.88quote price arrow up+0.07 (+0.79%)
Volume
16,096,277
52 week range
1.55 - 19.39

...

Loading . . .

KEY STATS

  • Open8.94
  • Day High8.94
  • Day Low7.92
  • Prev Close8.81
  • 52 Week High19.39
  • 52 Week High Date08/10/20
  • 52 Week Low1.55
  • 52 Week Low Date03/18/20
  • Market Cap2.489B
  • Shares Out280.32M
  • 10 Day Average Volume14.83M
  • Dividend-
  • Dividend Yield-
  • Beta2.51
  • 1 Year % Change301.81

RATIOS/PROFITABILITY

  • EPS (TTM)-1.32
  • P/E (TTM)-6.75
  • Fwd P/E (NTM)2.20
  • EBITDA (MRQ)-233.511M
  • ROE (MRQ)-244.90%
  • Revenue (MRQ)39.99M
  • Gross Margin (MRQ)75.14%
  • Net Margin (MRQ)-771.68%
  • Debt To Equity (MRQ)69.92%

EVENTS

  • Earnings Date05/13/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Sorrento Therapeutics Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Sorrento Therapeutics, Inc. is a clinical-stage and commercial biopharma company. The Company operates through two segments: Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next generation of cancer therapeutics. These modalities include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor...
Henry Ji Ph.D.
Chairman
Najjam Asghar
Chief Financial Officer
Address
4955 Directors Pl
San Diego, CA
92121-3836
United States